contributor
- Calder, Christopher Sub-Investigator - 2009
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects with Moderately Severe Diabetic Neuropathy, Sangamo Biosciences, Inc
Grant
- Affiliation